Search - tctmd.com

Displaying 221 - 240 of 912

Sort: Relevancy | Date

News Conference News TCT 2021

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

Yael L. Maxwell

October 22, 2021

News Daily News

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

October 15, 2021

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

Michael O'Riordan

September 30, 2021

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Caitlin E. Cox

September 15, 2021

News Daily News

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

L.A. McKeown

September 07, 2021

News Conference News ESC 2021

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

Shelley Wood

September 02, 2021

Presentation ESC 2021

One-month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy in Acute Coronary Syndrome:

Presenter: Hirotoshi Watanabe

August 31, 2021

News Conference News

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Shelley Wood

August 30, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Conference News ESC 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

Todd Neale

August 24, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Yael L. Maxwell

July 16, 2021

News

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

Yael L. Maxwell

July 13, 2021

News Daily News

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Yael L. Maxwell

July 01, 2021

New CV Surgery Guidelines Shift Focus to ‘Blood Management’

News Daily News

CV Surgery Societies Urge Shift to ‘Blood Management’

Yael L. Maxwell

June 30, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Daily News

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

L.A. McKeown

June 18, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Conference News EAS 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Michael O'Riordan

June 08, 2021

News Conference News ACC 2021

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

Yael L. Maxwell

May 26, 2021

Advertisement

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Women Stand to Gain the Most From Standardized STEMI Protocols

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

One-month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy in Acute Coronary Syndrome:

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

CV Surgery Societies Urge Shift to ‘Blood Management’

OMT Boosts Survival in Revascularized Patients at 10 Years

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content